-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $88 FROM $70

Reuters·09/23/2026 03:01:55

Please log in to view news